-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Protera Therapeutics (TARA)
-
-
-
-
-
-
-
Protara Therapeutics, Inc. (TARA) Tops Q1 EPS by 18c
-
-
-
-
-
-
-
Protara Therapeutics, Inc. (TARA) Tops Q4 EPS by 11c
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Protera Therapeutics (TARA)
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

